A randomised trial to investigate the therapeutic adding effect of mirabegron 50 mg in Asian overactive bladder patients after initial treatment of mirabegron 25 mg.
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 29 Nov 2017 New trial record